SABCS: Adding Camrelizumab to Neoadjuvant Chemo Beneficial in TNBC
Addition of camrelizumab improves pathological complete response in early or locally advanced triple negative breast cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.